Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1965 Aug;54(2):381–388. doi: 10.1073/pnas.54.2.381

Tumors induced in hamsters by a strain of adenovirus type 3: sharing of tumor antigens and "neoantigens" with those produced by adenovirus type 7 tumors.

R J Huebner, M J Casey, R M Chanock, K Schell
PMCID: PMC219674  PMID: 4285931

Full text

PDF
382

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARONSON B., ARONSON S., SOBEL G., WALKER D. Pharyngoconjunctival fever; report of an epidemic outbreak. AMA J Dis Child. 1956 Dec;92(6):596–612. [PubMed] [Google Scholar]
  2. BARR J., KJELLEN L., SVEDMYR A. Hospital outbreak of adenovirus type 3 infections: a clinical and virologic study on 38 patients partly involved in a nosocomial outbreak. Acta Paediatr. 1958 Jul;47(4):365–382. doi: 10.1111/j.1651-2227.1958.tb07648.x. [DOI] [PubMed] [Google Scholar]
  3. BELL J. A., ROWE W. P., ENGLER J. I., PARROTT R. H., HUEBNER R. J. Pharyngoconjunctival fever; epidemiological studies of a recently recognized disease entity. J Am Med Assoc. 1955 Mar 26;157(13):1083–1092. doi: 10.1001/jama.1955.02950300011003. [DOI] [PubMed] [Google Scholar]
  4. BELL J. A., ROWE W. P., ROSEN L. Acute respiratory diseases of viral etiology. II. Adenoviruses. Am J Public Health Nations Health. 1962 Jun;52:902–907. doi: 10.2105/ajph.52.6.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BINN L. N., HILLEMAN M. R., RODRIGUEZ J. E., GLABERE R. R. Antigenic relationships among adenoviruses with appraisal of reliability of complement-fixation test for typing isolates. J Immunol. 1958 Jun;80(6):501–508. [PubMed] [Google Scholar]
  6. DENNY F. W., Jr, GINSBERG H. S. Certain biological characteristics of adenovirus types 5, 6, 7 and 14. J Immunol. 1961 May;86:567–574. [PubMed] [Google Scholar]
  7. GINSBERG H. S. Biological and physical properties of the adenoviruses. Ann N Y Acad Sci. 1957 Apr 19;67(8):383–391. doi: 10.1111/j.1749-6632.1957.tb46061.x. [DOI] [PubMed] [Google Scholar]
  8. GINSBERG H. S. Characteristics of the new respiratory viruses (adenoviruses). I. Qualitative and quantitative aspects of the neutralization reaction. J Immunol. 1956 Oct;77(4):271–278. [PubMed] [Google Scholar]
  9. GIRARDI A. J., HILLEMAN M. R., ZWICKEY R. E. TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES INCLUDING ADENOVIRUS TYPE 7. Proc Soc Exp Biol Med. 1964 Apr;115:1141–1150. doi: 10.3181/00379727-115-29138. [DOI] [PubMed] [Google Scholar]
  10. GRAYSTON J. T., JOHNSTON P. B., LOOSLI C. G., SMITH M. E., WOOLRIDGE R. L. Neutralizing and complement fixing antibody response to adenovirus infection. J Infect Dis. 1956 Sep-Oct;99(2):199–206. doi: 10.1093/infdis/99.2.199. [DOI] [PubMed] [Google Scholar]
  11. HABEL K. SPECIFIC COMPLEMENT-FIXING ANTIGENS IN POLYOMA TUMORS AND TRANSFORMED CELLS. Virology. 1965 Jan;25:55–61. doi: 10.1016/0042-6822(65)90251-5. [DOI] [PubMed] [Google Scholar]
  12. HILLEMAN M. R., FLATLEY F. J., ANDERSON S. A., LUECKING M. L., LEVINSON D. J. Antibody response in volunteers to adenovirus vaccine and correlation of antibody with immunity. J Immunol. 1958 Apr;80(4):299–307. [PubMed] [Google Scholar]
  13. HOGGAN M. D., ROWE W. P., BLACK P. H., HUEBNER R. J. PRODUCTION OF "TUMOR-SPECIFIC" ANTIGENS BY ONCOGENIC VIRUSES DURING ACUTE CYTOLYTIC INFECTIONS. Proc Natl Acad Sci U S A. 1965 Jan;53:12–19. doi: 10.1073/pnas.53.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HUEBNER R. J., ROWE W. P., CHANOCK R. M. Newly recognized respiratory tract viruses. Annu Rev Microbiol. 1958;12:49–76. doi: 10.1146/annurev.mi.12.100158.000405. [DOI] [PubMed] [Google Scholar]
  15. HUEBNER R. J., ROWE W. P., LANE W. T. Oncogenic effects in hamsters of human adenovirus types 12 and 18. Proc Natl Acad Sci U S A. 1962 Dec 15;48:2051–2058. doi: 10.1073/pnas.48.12.2051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HUEBNER R. J., ROWE W. P., TURNER H. C., LANE W. T. SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS. Proc Natl Acad Sci U S A. 1963 Aug;50:379–389. doi: 10.1073/pnas.50.2.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. JACKSON G. G. Viruses of the upper respiratory tract. Annu Rev Med. 1956;7:1–24. doi: 10.1146/annurev.me.07.020156.000245. [DOI] [PubMed] [Google Scholar]
  18. JORDAN W. S., Jr Occurrence of adenovirus infections in civilian populations. AMA Arch Intern Med. 1958 Jan;101(1):54–59. doi: 10.1001/archinte.1958.00260130068006. [DOI] [PubMed] [Google Scholar]
  19. KENDALL E. J., RIDDLE R. W., TUCK H. A., RODAN K. S., ANDREWS B. E., MCDONALD J. C. Pharyngo-conjunctival fever; school outbreaks in England during the summer of 1955 associated with adenovirus types 3, 7, and 14. Br Med J. 1957 Jul 20;2(5037):131–136. doi: 10.1136/bmj.2.5037.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. KJELLEN L., ZETTERBERG B., SVEDMYR A. An epidemic among Swedish children caused by adenovirus type 3. Acta Paediatr. 1957 Nov;46(6):561–568. doi: 10.1111/j.1651-2227.1957.tb14484.x. [DOI] [PubMed] [Google Scholar]
  21. NOLAN K., DOHERTY R. L., HART D., BIGGS T. R. Adenovirus type 3 infection in Brisbane. Med J Aust. 1962 Feb 17;49(1):236–238. doi: 10.5694/j.1326-5377.1962.tb25851.x. [DOI] [PubMed] [Google Scholar]
  22. PARROTT R. H., ROWE W. P., HUEBNER R. J., BERNTON H. W., McCULLOUGH N. B. Outbreak of febrile pharyngitis and conjunctivitis associated with type 3 adenoidal-pharyngeal-conjunctival virus infection. N Engl J Med. 1954 Dec 30;251(27):1087–1090. doi: 10.1056/NEJM195412302512702. [DOI] [PubMed] [Google Scholar]
  23. PEREIRA M. S., PERIERA H. G., CLARKE S. K. HUMAN ADENOVIRUS TYPE 31. A NEW SEROTYPE WITH ONCOGENIC PROPERTIES. Lancet. 1965 Jan 2;1(7375):21–23. doi: 10.1016/s0140-6736(65)90925-6. [DOI] [PubMed] [Google Scholar]
  24. POPE J. H., ROWE W. P. DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCE. J Exp Med. 1964 Aug 1;120:121–128. doi: 10.1084/jem.120.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. RAFAJKO R. R. PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA. Am J Hyg. 1964 May;79:310–319. doi: 10.1093/oxfordjournals.aje.a120385. [DOI] [PubMed] [Google Scholar]
  26. RAPP F., BUTEL J. S., MELNICK J. L. VIRUS-INDUCED INTRANUCLEAR ANTIGEN IN CELLS TRANSFORMED BY PAPOVAVIRUS SV40. Proc Soc Exp Biol Med. 1964 Aug-Sep;116:1131–1135. doi: 10.3181/00379727-116-29472. [DOI] [PubMed] [Google Scholar]
  27. ROSEN L. A hemagglutination-inhibition technique for typing adenoviruses. Am J Hyg. 1960 Jan;71:120–128. doi: 10.1093/oxfordjournals.aje.a120085. [DOI] [PubMed] [Google Scholar]
  28. ROSEN L., BARON S., BELL J. A. Four newly recognized adenoviruses. Proc Soc Exp Biol Med. 1961 Jun;107:434–437. doi: 10.3181/00379727-107-26648. [DOI] [PubMed] [Google Scholar]
  29. ROWE W. P., HARTLEY J. W., HUEBNER R. J. Serotype composition of the adenovirus group. Proc Soc Exp Biol Med. 1958 Feb;97(2):465–470. doi: 10.3181/00379727-97-23776. [DOI] [PubMed] [Google Scholar]
  30. SABIN A. B., KOCH M. A. BEHAVIOR OF NONINFECTIOUS SV 40 VIRAL GENOME IN HAMSTER TUMOR CELLS: INDUCTION OF SYNTHESIS OF INFECTIOUS VIRUS. Proc Natl Acad Sci U S A. 1963 Sep;50:407–417. doi: 10.1073/pnas.50.3.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. SABIN A. B., SHEIN H. M., KOCH M. A., ENDERS J. F. SPECIFIC COMPLEMENT-FIXING TUMOR ANTIGENS IN HUMAN CELLS MORPHOLOGICALLY TRANSFORMED BY SV40 VIRUS. Proc Natl Acad Sci U S A. 1964 Dec;52:1316–1318. doi: 10.1073/pnas.52.6.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. SCHMIDT N. J., KING C. J., LENNETTE E. H. HEMAGGLUTINATION AND HEMAGGLUTINATION-INHIBITION WITH ADENOVIRUS TYPE 12. Proc Soc Exp Biol Med. 1965 Jan;118:208–212. doi: 10.3181/00379727-118-29799. [DOI] [PubMed] [Google Scholar]
  33. TAI F. H., GRAYSTON J. T. Adenovirus neutralizing antibodies in persons on Taiwan. Proc Soc Exp Biol Med. 1962 Apr;109:881–884. doi: 10.3181/00379727-109-27366. [DOI] [PubMed] [Google Scholar]
  34. TRENTIN J. J., YABE Y., TAYLOR G. The quest for human cancer viruses. Science. 1962 Sep 14;137(3533):835–841. doi: 10.1126/science.137.3533.835. [DOI] [PubMed] [Google Scholar]
  35. UCHIDA S., HOSHIKA T., YAMAMOTO H., KOIKE K., KOSEKI S., FURUNO A. Relationships between types of adenovirus indicated by heterologous neutralization. Jpn J Exp Med. 1959 Apr;29(2):121–129. [PubMed] [Google Scholar]
  36. VAN DER VEEN J., DIJKMAN J. H. Association of type 21 adenovirus with acute respiratory illness in military recruits. Am J Hyg. 1962 Sep;76:149–159. doi: 10.1093/oxfordjournals.aje.a120270. [DOI] [PubMed] [Google Scholar]
  37. VAN DER VEEN J., KOK G. Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in The Netherlands. Am J Hyg. 1957 Mar;65(2):119–129. doi: 10.1093/oxfordjournals.aje.a119860. [DOI] [PubMed] [Google Scholar]
  38. WIGAND R., BAUER H., LANG F., ADAM W. NEUTRALIZATION OF THE ADENOVIRUSES TYPES 1 TO 28: SPECIFICITY AND ANTIGENIC RELATIONSHIPS. Arch Gesamte Virusforsch. 1965;15:188–199. doi: 10.1007/BF01257730. [DOI] [PubMed] [Google Scholar]
  39. van der VEEN, PRINS A. Studies of the significance of the recall phenomenon in the antibody response to adenovirus vaccine and infection. J Immunol. 1960 Jun;84:562–568. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES